Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
Submitted by
admin
on November 12, 2013 - 7:59am
Source:
TheStreet.com
News Tags:
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Headline:
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
Do Not Allow Advertisers to Use My Personal information
